CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Teva, Samsung Bioepis Partner to Commercialize Eylea Biosimilar Opuviz in Canada

PartnershipOpuvizPositive
AI Analysis

Summary

Teva Pharmaceutical and Samsung Bioepis have entered into a partnership to commercialize Opuviz, a biosimilar of Eylea, in Canada.

Importance:6/10
Sentiment:
0.50
biosimilarpartnershipcommercializationCanadaophthalmology
Related Companies

Read the original article

Published by yahoo_finance on July 9, 2026 12:37 PM

Read Original